Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid
- PMID: 2415092
- DOI: 10.1001/archneur.1985.04060110040013
Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid
Abstract
Serotonin (5-HT), its precursor 5-hydroxytryptophan (5-HTP), and its major metabolite 5-hydroxyindoleacetic acid (5-HIAA) were measured in the cerebrospinal fluid (CSF) of 14 patients with dementia of the Alzheimer type (DAT) and in nine controls by high-performance liquid chromatography with a novel multisensor coulometric detection system. Concentrations of both 5-HT and 5-HIAA detected by this system were lower than the concentrations obtained using conventional amperometric detection. This difference was caused by coelution of compounds that could be resolved from 5-HT and 5-HIAA by the multisensor coulometric system. One of the coelution compounds, observed in DAT but not in control CSF, behaved like a partially oxidized 5-HT. A compound behaving like partially oxidized 5-HTP was also observed in DAT CSF. Concentrations of 5-HTP, 5-HT, and 5-HIAA were lower in DAT CSF than in a corresponding fraction of control CSF. These results indicate involvement of the serotoninergic system in DAT and might lead to development of a diagnostic test for DAT.
Similar articles
-
Serotonin and 5-hydroxyindoleacetic acid in CSF. Difference in Parkinson's disease and dementia of the Alzheimer's type.Arch Neurol. 1985 Feb;42(2):127-9. doi: 10.1001/archneur.1985.04060020037011. Arch Neurol. 1985. PMID: 2579625
-
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.Acta Neurol Scand. 1981 Aug;64(2):101-7. doi: 10.1111/j.1600-0404.1981.tb04392.x. Acta Neurol Scand. 1981. PMID: 6172950
-
CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly.J Neural Transm Suppl. 1990;30:45-55. doi: 10.1007/978-3-7091-3345-3_5. J Neural Transm Suppl. 1990. PMID: 1697333
-
Neurotoxic properties of a serotonin oxidation product: possible role in Alzheimer's disease.Prog Clin Biol Res. 1989;317:453-65. Prog Clin Biol Res. 1989. PMID: 2481322 Review.
-
Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's dementia.J Neural Transm Suppl. 1990;30:33-43. doi: 10.1007/978-3-7091-3345-3_4. J Neural Transm Suppl. 1990. PMID: 2202785 Review.
Cited by
-
Opioid use affects antioxidant activity and purine metabolism: preliminary results.Hum Psychopharmacol. 2009 Dec;24(8):666-75. doi: 10.1002/hup.1068. Hum Psychopharmacol. 2009. PMID: 19760630 Free PMC article.
-
Recent advances in the application of metabolomics to Alzheimer's Disease.Biochim Biophys Acta. 2014 Aug;1842(8):1232-9. doi: 10.1016/j.bbadis.2013.06.014. Epub 2013 Jun 29. Biochim Biophys Acta. 2014. PMID: 23816564 Free PMC article. Review.
-
Peroxidase-promoted oxidation and peroxidation of the serotonergic neurotoxin 5,7-dihydroxytryptamine. A new pathway for its metabolic degradation.Mol Cell Biochem. 1992 May 13;112(1):35-44. doi: 10.1007/BF00229641. Mol Cell Biochem. 1992. PMID: 1513333
-
Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid.ACS Chem Neurosci. 2024 Feb 7;15(3):582-592. doi: 10.1021/acschemneuro.3c00611. Epub 2024 Jan 9. ACS Chem Neurosci. 2024. PMID: 38194490 Free PMC article.
-
Extracts of Sideritis scardica and Clinopodium vulgare Alleviate Cognitive Impairments in Scopolamine-Induced Rat Dementia.Int J Mol Sci. 2024 Feb 2;25(3):1840. doi: 10.3390/ijms25031840. Int J Mol Sci. 2024. PMID: 38339117 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical